Avalo Therapeutics (AVTX) Shares Outstanding (Entity) (2015 - 2023)
Avalo Therapeutics (AVTX) Shares Outstanding (Entity) (2015 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Entity.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 254.16 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 200.18 Mn |
| 10 | Avalo Therapeutics | 371.17 Mn | 371.17 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 58,534.00 |
| Mar 31, 2023 | 55,046.00 |
| Dec 31, 2022 | 39,325.00 |
| Sep 30, 2022 | 1.00 |
| Jun 30, 2022 | 583.00 |
| Mar 31, 2022 | 583.00 |
| Dec 31, 2021 | 583.00 |
| Sep 30, 2021 | 39,029.00 |
| Jun 30, 2021 | 33,362.00 |
| Mar 31, 2021 | 30,963.00 |
| Dec 31, 2020 | 26,063.00 |
| Sep 30, 2020 | 26,027.00 |
| Jun 30, 2020 | 26,027.00 |
| Mar 31, 2020 | 20,696.00 |
| Dec 31, 2019 | 15,423.00 |
| Sep 30, 2019 | 15,326.00 |
| Jun 30, 2019 | 14,907.00 |
| Mar 31, 2019 | 14,856.00 |
| Dec 31, 2018 | 14,179.00 |
| Sep 30, 2018 | 14,136.00 |